Communiqués Valeo Pharma Inc.

Actions

VPH

CA91915B1085

Temps Différé Toronto S.E. Autres places de cotation 18:33:20 17/07/2024			Varia. 5j.	Varia. 1 janv.
0,11 ^CAD	-4,35 %		+10,00 %	-38,89 %

18/06	Valeo Pharma nomme un directeur du développement, en hausse de près de 22%.	MT
18/06	Valeo Pharma Inc. nomme Al Moghaddam au poste de Directeur du développement et quitte par conséquent son Conseil d'administration	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE	18/06	AQ
Valeo Pharma hits record 2nd quarter revenue as demand for Asthma products continues to rise	17/06	AQ
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES	13/06	AQ
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY	13/06	AQ
VALEO PHARMA TO HOST SECOND QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST	04/06	AQ
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS	25/04	AQ
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE	09/04	AQ
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	25/03	AQ
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	22/03	AQ
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS	14/03	AQ
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL, WEBCAST	08/03	AQ
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST	07/03	AQ
VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGES	13/02	AQ
VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP	02/02	AQ
VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023	29/01	AQ
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL, WEBCAST	23/01	AQ
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCAST	22/01	AQ
Valeo Pharma announces new chief financial officer along with $2 million in cost reductions	21/11	AQ
VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVES	20/11	AQ
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS	07/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Valeo Pharma Inc.

Actions

VPH

CA91915B1085

Communiqués

Filtres